In a meeting between specialist doctors both nationally and internationalSanofi announced the launch of their new medicine, which helps more effectively to fight diabetes.
Dr. Guillermo González Gálvez, an endocrinologist of the Dr. Juan I. Menchaca Civil Hospital, announced that, according to INEGI data, there were 98 thousand deaths for diabetes in Mexico during 2015, and “it is estimated that around 10 millionpeople will develop it in the coming years.Every year between 300 thousand and 320 thousand new cases.From the population that suffers from it, it is estimated that only 50% know that they suffer from this disease. ”
González released a study that was conducted in England to Mexican patients who had an average of 8.9 of glucosylated hemoglobin and used urea sulfonyl.The results showed that although the disease was fought in the short term, the subjects were more predisposed to die.
much more friendly with the patient
Another specialists, Oscar Lozano Castañeda, doctor of the National Institute of Medical Sciences and Nutrition Rafael Zubirán, talked about the benefits of using the new medication insulin Glargina U300.While previously the medicine should be injected subcutaneously or intramuscularly in well -defined periods with a needle of larger dimensions, the new medicine can be injected by the same patient, following the pre -established hours, with a kind of pen that has a small needle a small needle, and with already predetermined dose.The only thing the patient should do is apply in different places every day: around the navel, in the buttocks, on the thighs or in the arms.
“You have to do that but, above all, you have to wear a healthy diet and practice daily.Especially for pre-diabetic patients, who may have glucose levels of 99 mg/dl up to 125 mg/dl in the blood, they are suggested, at least half an hour of walking for five days a week.This practice can reduce the risk of triggering diabetes by up to 31%, ”he said.Similarly, it recommends abstention in the consumption of high glucose products or other sugars, such as soft drinks, processed juices, energy and sweeteners in general.
How does it work?
Dr. Fernando Javier Lavalle González, coordinator of the José Eleuterio González University Hospital, in Nuevo León, explained that the insulin Glargina U300 has only 1/3 of the concentration of which the previous version had, the U100, so the assimilation ofThe U300 is carried out in a more dosed and better distributed way, thus avoiding hypoglycemic peaks.
Finally, Dr. Robert Ritz, of the Endocrinology and Diabetes Division at the General Hospital of Germany, stressed that when using this new ally, the risk of the patient to suffer hypoglycemia from 20 to 30%, in addition to reducing the risk ofthat arrhythmias or insufficiency of irrigation in blood vessels are suffered.
He stressed that, among other advantages, there is also less weight gain for the use of insulins after six months of administration in patients.And he acknowledged that although its use has shown that the medicine can be used successfully in the short term, studies are still missing to determine its effects in the long period, but stressed that it is a good alternative in treatment for patients suffering from this irreversibleillness, by providing them with a more hopeful panorama in their quality of life.
This works
Insulin is theintermediary that helps glucose be assimilated by cells.When it does not occur, or when the cells cannot assimilate, diabetes mellitus type I or type II occurs.
Although insulin in principle was extracted from corpses, then it was obtained for its commercial exploitation of pigs, whose DNA structure is very similar to the structure of the DNA of human cells.
When the DNA is added to the plasmids, human insulin is obtained that can be used pharmaceutically.When this type of insulin is added proline and lysine amino acids, lipro insulin is obtained.
When adding aspartic acid, the medicine has rapid assimilation.The assimilation of basal insulin lasts 24 hours.
By adding arginine and glargine amino acids, the action of the medication is more prolonged and better distributed, so there are no hypoglycemia peaks.
